Sofinnova Partners SAS - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for Quince Therapeutics, Inc. (QNCX)

Filing Manager
Sofinnova Partners SAS
Reporting Manager
Sofinnova Capital VIII
Security
Quince Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
QNCX
Shares outstanding
44.4M shares
Disclosed Ownership
2.4M shares
Ownership
5.4%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 04:29 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Capital VIII 5.4% 2.4M 2.4M 0 Antoine Papiernik Managing Partner
Sofinnova Partners SAS, a French corporation 5.4% 2.4M 2.4M 0 Antoine Papiernik Managing Partner
Antoine Papiernik 5.4% 2.4M 2.4M 0 Antoine Papiernik Antoine Papiernik
Henrijette Richter 5.4% 2.4M 2.4M 0 Henrijette Richter Henrijette Richter
Maina Bhaman 5.4% 2.4M 2.4M 0 Maina Bhaman Maina Bhaman
Graziano Seghezzi 5.4% 2.4M 2.4M 0 Graziano Seghezzi Graziano Seghezzi
Anta Gkelou 5.4% 2.4M 2.4M 0 Anta Gkelou Anta Gkelou
Karl Naegler 5.4% 2.4M 2.4M 0 Karl Naegler Karl Naegler